Ets-1 regulates its target genes mainly by DNA methylation in human ovarian cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ovarian cancer is a leading gynecological malignancy with incompletely understood molecular drivers.
• Ets-1, an Ets transcription factor, is implicated in cancer progression, including extracellular matrix remodeling, invasion, angiogenesis, and drug resistance.

Purpose of the Study:

• To computationally analyze gene expression profiles and explore the regulatory mechanism of Ets-1 in ovarian cancer.
• To identify genes regulated by Ets-1 and investigate their functional roles and methylation status in ovarian cancer.

Main Methods:

• Downloaded and analyzed two gene expression datasets from the Gene Expression Omnibus (GEO) database.
• Performed microarray analysis to identify Ets-1-regulated genes (differentially expressed genes - DEGs).
• Conducted functional annotation of DEGs and DNA methylation analysis.

Main Results:

• Identified 548 genes regulated by Ets-1 in ovarian cancer.
• Functional annotation indicated Ets-1's involvement in system development, response to stimulus, vascular endothelial growth factor (VEGF) production, morphogenesis, cell proliferation, cell adhesion, and signal transduction.
• Found that 26.5% (145) of the identified DEGs were differentially methylated in ovarian cancer.

Conclusions:

• Ets-1 plays a significant role in regulating multiple biological processes crucial for ovarian cancer progression.
• The findings provide insights into the transcriptional regulation mechanisms of Ets-1 target genes in ovarian cancer.
• Differential methylation of Ets-1 target genes suggests epigenetic modifications contribute to ovarian cancer development.